Expression of Ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of Ets-1 and matrix metalloproteinase-3

Head and Neck

Volumn 27, Issue 7, 2005, Pages 585-596

  Horváth, Barnabás ^a   Hegyesi, Hargita ^b   Nagy, Pál ^a   Falus, András ^b   Schaff, Zsuzsa ^b  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Ets 1; Fibroblast; Head and neck cancer; Histamine; Metastasis; MMP 3

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HISTAMINE; STROMELYSIN; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HISTAMINE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HISTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 3; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 21844445880     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20188     Document Type: Article

References (45)

1. Bronchud MH, Foote M, Peters WP, Robinson MO. Principles of molecular oncology. New Jersey: Humana Press; 2000. p 309.
2. Bejarano PA, Noelken ME, Suzuki K, Hudson BG, Nagase H. Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem J 1988;256:413-419.
3. Nicholson R, Murphy G, Breathnach R. Human and rat malignant-tumor associated mRNAs encode stromelysin-like metalloproteinases. Biochemistry 1989;28:5195-5203.
4. Leprince D, Gegonne A, Coll J, de Taisne C, Sahnneberger A, Lagron C. A putativa second cell derived oncogene of avian leukemia retrovirus E26. Nature 1983;306:395-397.
5. Nakayama T, Ito M, Ohtsuru A, et al. Expression of the Ets-1 proto-oncogene in human gastric carcinoma. Am J Pathol 1996;149:1931-1939.
6. Wernert N, Gilles F, Fafeur V. Stromal expression of c-ets-1 transcription factor correlates with tumor invasion. Cancer Res 1994;54:5683-5688.
7. Pande P, Mathur M, Shukla NK, Ralhan R. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J Pathol 1989;189:40-45.
8. Bolon I, Gouyer V, Devouassoux M, et al. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 1995; 147:1298-1310.
9. Chen Z, Fisher RJ, Li B, et al. Elevated expression of ETS-1 gene in a metastatic, tumorigenic human prostate epithelial cell line transformed by the v-Ki-ras oncogene. Int J Oncol 1997;11:1179-1184.
10. Ito T, Nakayama T, Ito M, Naito S, Kanematsu T, Sekine I. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Mod Pathol 1998;11:209-215.
11. Saeki H, Kuwano H, Kawaguchi H, Ohno S, Sugimachi K. Expression of Ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 2000;89:1670-1676.
12. Ozaki I, Mizuta T, Zhao G, et al. Involvement of Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000;60:6519-6525.
13. Naito S, Shimizu K, Nakashima M, et al. Overexpression of ets-1 transcription factor in angiosarcoma of the skin. Pathol Res Pract 2000;196:103-109.
14. Ito Y, Miyoshi E, Takeda T, et al. Ets-1 expression in extrahepatic bile duct carcinoma and cholangiocellular carcinoma. Oncology 2000;58:248-252.
15. Kitange G, Tsonuda K, Anda T, et al. Immunohistochemical expression of ets-1 transcription factor and urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas. Cancer 2000;89:2292-2300.
16. Zipori D. Stromal cells in tumor growth and regression. Cancer J 1994;3:164-169.
17. Tisty TD, Hein PW. Know the neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11:54-59.
18. Ryoo YW, Kwon HJ, Lee KS. Interferon-γ regulates stromelysin-1 gene expression in human skin fibroblasts. J Dermatol Sci 1996;12:189-194.
19. Gogly B, Hornebeck W, Groult N, Godeau G, Pellat B. Influence of heparin(s) on the interleukin-1-β-induced expression of collagenase, stromelysin-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts. Biochem Pharmacol 1998;56:1447-1454.
20. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989; 109:1-6.
21. Dellacono FR, Spiro J, Eisma R, Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 1997;174:540-544.
22. Zauberman H, Michaelson IC, Bergmann F, Maurice DM. Stimulation of neovascularization of the cornea by biogenic amines. Exp Eye Res 1969;8:77-83.
23. Fraser RA, Simpson JG. Role of mast cells in experimental tumour angiogenesis. In: Development of the vascular system (Ciba Foundation Symposium 100), London: Pitman; 1983. p 120-131.
24. Zenmyo M, Hiraoka K, Komiya S, Morimatsu M, Sasaguri Y. Histamine-stimulated production of matrix metalloproteinase 1 ba human rheumatoid synovial fibroblasts is mediated by histamine H1-receptor. Virchows Arch 1995;427:437-444.
25. Garcia-Caballero M, Brandes LJ, Hosoda S. Histamine in normal and cancer cell proliferation. Oxford: Pergamon Press; 1993.
26. Haak-Frendscho M, Darvas Z, Hegyesi H, et al. Related articles, links histidine decarboxylase expression in human melanoma. J Invest Dermatol 2000;115:345-352.
27. Reynolds JL, Akhter JA, Magarey CJ, Schwartz P, Adams WJ, Morris DL. Histamine in human breast cancer. Br J Surg 1998;85:535-541.
28. Falus A, Hegyesi H, Lázár-Molnár E, Pós Z, László V, Darvas ZS. Paracrine and autocrine interaction in melanoma: histamine is a relevant player in local regulation. Trends Immunol 2001;22:648-652.
29. Hegyesi H, Somlai B, Varga VL, et al. Suppression of melanoma cell proliferation by histidine decarboxylase specific. J Invest Dermatol 2001;117:151-153.
30. Matrisian LM, Bowden GT, Krieg P, et al. The mRNA coding for the secreted protease is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A 1989;83:9413-9417.
31. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990;9:2241-2246.
32. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The Ets-1 oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoprotein. EMBO J 1991;10:1127-1134.
33. Gilles Ch, Polette M, Birembaut Ph, Brünner N, Thompson EW. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis 1997;15:519-526.
34. Borchers AH, Powell MB, Fusenig NE, Bowden T. Paracrine factor and cell-cell contact-mediated induction of proteinase and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res 1994;213:143-147.
35. Gilles F, Raes MB, Stehelin D, Vandenbunder B, Fafeur V. The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res 1996;222:370-378.
36. Calmels TPG, Matot V, Wernert N, Vandenbunder B, Stehelin D. Invasive tumors induce c-ets-1 transcription factor expression in adjacent stroma. Biol Cell 1995;84:53-61.
37. Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinases and migration of vascular endothelial cells. J Cell Physiol 1996;169:522-531.
38. Garcia-Caballero M, Neugebauer E, Rodriguez F, et al. Changes is histamine synthesis, tissue content and catabolism in human breast cancer. Agents Action 1989;27:227-231.
39. Dimitriadou V, Koutsilieris M. Mast cell-tumor cell interaction. Anticancer Res 1997;17:1541-1550.
40. Garcia-Caballero M, Neugebauer E, Rodroguez F, Nunez De Castro I, Vara-Thorbeck C. Histamine synthesis and content in benign and malignant tumors. Its effect on other host tissue. Surg Oncology 1994;3:167-173.
41. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol 1989;20:159-164.
42. Jeziorska M, Haboubi NY, Schofield PF, Woolley DE. Mast cell distribution and tumour cell proliferation in colonic carcinoma. Gut 1993;34(Suppl 1):S5.
43. Leonardi A, Radice M, Fregona IA, Plebani M, Abatangelo G, Secchi AG. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. Exp Eye Res 1999;68:739-746.
44. Hahm KB, Park IS, Kim HC, et al. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. Int J Immunopharmacol 1996;18:393-399.
45. Kikuchi K, Kadono T, Takehara K. Effects of various growth factor and histamine on cultured keloid fibroblasts. Dermatology 1995;190:4-8.